Analysis of current perioperative management with Haemate® P/Humate P® in von Willebrand disease: Identifying the need for personalized treatment.
H C A M HazendonkJessica M HeijdraN C B de JagerH C VeermanJ BoenderI van MoortR A A MathôtK MeijerB A P Laros-van GorkomJ EikenboomK FijnvandraatFrank W G LeebeekM H Cnossennull nullPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2018)
High VWF:Act and accumulation of FVIII were observed after perioperative FVIII-based replacement therapy in patients with VWD, both underlining the necessity of personalization of dosing regimens to optimize perioperative treatment.